Efflux pumps in bacteria: overview, clinical relevance, and potential pharmaceutical target.
Trends in microbial resistance suggest a dramatic increase in the frequency of reports of multi-drug efflux pumps in bacteria and fungi. Although it is difficult to determine whether this increase is due to the increased attention given to this resistance mechanism, or an increase in frequency, efflux pumps are becoming an important consideration in resistance emergence. These efflux pumps comprise at least four different classes in Gram-positive and Gram-negative bacteria, as well as in Streptomyces and fungi. As more efflux pumps are characterised and studied, both biochemically and structurally, the opportunity for intervention may arise.
Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492, USA.
L E
LE
Lawrence
J F
JF
Barrett